Search for: "Sanofi-Aventis"
Results 201 - 220
of 561
Sorted by Relevance
|
Sort by Date
14 Mar 2014, 1:02 pm
., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
15 Oct 2020, 9:40 pm
Sanofi-Aventis U.S. [read post]
5 Feb 2018, 9:59 pm
Sanofi Aventis Deutschland GmbH PTAB Petition: IPR2017-01526; filed June 5, 2017. [read post]
15 Jun 2014, 8:46 pm
Patent No. 7,022,340 ("Pharmaceutical Composition as Solid Dosage Form and Method for Manufacturing Thereof," issued April 4, 2006) in conjunction with Glenmark's Paragraph IV certification as part of its filing of an ANDA to manufacture a generic version of Sanofi-Aventis' DDAVP® Tablets... [read post]
26 Aug 2019, 4:15 am
Pfizer saw a lot of success last week in having seven IPRs instituted against Sanofi-Aventis, challenging four injectable insulin treatment patents that are at the center of district court infringement litigation between the two parties. [read post]
26 Jul 2016, 8:45 pm
.; Sanofi-Aventis U.S. [read post]
11 Jul 2009, 3:25 am
Plavix is made by Sanofi-Aventis and Bristol-Myers Squibb. [read post]
14 Aug 2007, 1:54 am
Preventable blood clots that travel to the lungs could be responsible for 5% to 10% of hospital deaths, according to a study recently published in the American Journal of Hematology, and supported by funding from Sanofi-Aventis, a manufacturer of pharmaceuticals which include blood thinners. [read post]
21 Dec 2009, 7:51 am
This morning, the big news in deal-land is that Sanofi-Aventis (SNY) is buying Chattem Inc. [read post]
17 Oct 2008, 10:09 am
After UK's National Institute for Health and Clinical Excellence (NICE) agreed to pay for Roche's anticancer drug Tarceva on the condition that Tarceva should matched the price of an older, less costly remedy Taxotere, Roche discounted Tarceva by about $ 1000 in order to bring the cost in line with Taxotere (Docetaxel) marketed by Sanofi-Aventis. [read post]
24 Oct 2011, 8:29 am
There are growing safety concerns over the anti-arrhythmia drug Multaq, (dronedarone), which is manufactured and marketed by Sanofi-Aventis and has generated a great deal of controversy and concern in just a few short years. [read post]
24 Oct 2011, 8:29 am
There are growing safety concerns over the anti-arrhythmia drug Multaq, (dronedarone), which is manufactured and marketed by Sanofi-Aventis and has generated a great deal of controversy and concern in just a few short years. [read post]
19 Jun 2007, 8:21 am
Sanofi-Synthelabo et al. v. [read post]
26 Jan 2007, 6:09 am
In August 2006, generic drug maker Apotex Inc. began selling a cheaper version of Plavix, a blood thinner Bristol-Myers co-markets with Sanofi-Aventis SA, after an agreement to settle a patent dispute fell apart. [read post]
17 Oct 2018, 8:16 am
Minnesota Attorney General Lori Swanson filed a lawsuit Tuesday in the US District Court for the District of New Jersey alleging insulin manufacturers Sanofi-Aventis US, Novo Nordisk and Eli Lilly deceptively raised insulin prices. [read post]
13 Jun 2013, 5:12 am
On December 21, 2009, Sanofi-Aventis, a French pharmaceutical company, announced a tender offer for Chattem, a Tennessee-based distributor of over-the-counter pharmaceutical products, at the price of $93.50 per share. [read post]
13 Jun 2013, 5:12 am
On December 21, 2009, Sanofi-Aventis, a French pharmaceutical company, announced a tender offer for Chattem, a Tennessee-based distributor of over-the-counter pharmaceutical products, at the price of $93.50 per share. [read post]
30 Oct 2014, 8:21 am
Here's the Court's official summary - which doesn't necessarily indicate precisely what the real issues will turn out to be:35886Sanofi-Aventis, et al. v. [read post]
8 Jun 2013, 6:00 pm
According to a status report provided by the makers of Plavix, Bristol-Myers Squibb and Sanofi-Aventis, there are complaints with a total of 1,036 individual claims contained in those lawsuits that have been recently transferred to the MDL court. [read post]
18 Mar 2010, 8:10 am
But, Sanofi-Aventis now just looks bad for canceling the conversation. [read post]
